HALO:BMV
Halozyme Therapeutics, Inc.
1.955,00 MXN
arrow_downward
−0,70%(−13,69) 1D
1. lis, 13:46:16 GMT -6 · MXN
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za HALO...
Trž. kap.
13,26 mlr.
Prosj. kol.
440,00
Količina
0,00
52-tjed. najviša
1.970,00 MXN
52-tjed. najniža
1.126,00 MXN
Broj djelatnika
423
Trž. kap.
13,26 mlr.
Prosj. kol.
440,00
Količina
0,00
52-tjed. najviša
1.970,00 MXN
52-tjed. najniža
1.126,00 MXN
Broj djelatnika
423
Vijesti
Iz web-izvora i od partnera za vijesti
Timothy Sykes
·
prije 9 sati
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
StocksToTrade
·
prije 9 sati
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Simply Wall Street
·
prije 10 sati
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
StocksToTrade
·
prije 11 sati
HALO Stock Climbs As Patent Win Fuels Bullish Targets
Profil
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Halozyme Therapeutics, Inc. – informacije
Glavni izvršni direktorHelen I. Torley
Zaposlenici423
Osnovano1998
SjedišteSan Diego, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijahalozyme.com